Intended for healthcare professionals

News

FDA approves first over-the-counter blood glucose monitor for diabetes

BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q611 (Published 11 March 2024) Cite this as: BMJ 2024;384:q611
  1. Janice Hopkins Tanne
  1. New York

The US Food and Drug Administration (FDA) has approved the first over-the-counter continuous blood glucose monitor.1

The Stelo Glucose Biosensor System is manufactured by Dexcom and will be available in the US this summer. It is intended for people over the age of 18 who do not use insulin, such as people who are treating their diabetes with oral …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription